{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:17:36Z","timestamp":1791908256533,"version":"4.3.4"},"reference-count":116,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Australian National Heart Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Until recently, it has been generally held that stable angina pectoris (SAP) primarily reflects the presence of epicardial coronary artery stenoses due to atheromatous plaque(s), while acute myocardial infarction (AMI) results from thrombus formation on ruptured plaques. This concept is now challenged, especially by results of the ORBITA and ISCHEMIA trials, which showed that angioplasty\/stenting does not substantially relieve SAP symptoms or prevent AMI or death in such patients. These disappointing outcomes serve to redirect attention towards anomalies of small coronary physiology. Recent studies suggest that coronary microvasculature is often both structurally and physiologically abnormal irrespective of the presence or absence of large coronary artery stenoses. Structural remodelling of the coronary microvasculature appears to be induced primarily by inflammation initiated by mast cell, platelet, and neutrophil activation, leading to erosion of the endothelial glycocalyx. This leads to the disruption of laminar flow and the facilitation of endothelial platelet interaction. Glycocalyx shedding has been implicated in the pathophysiology of coronary artery spasm, cardiovascular ageing, AMI, and viral vasculitis. Physiological dysfunction is closely linked to structural remodelling and occurs in most patients with myocardial ischemia, irrespective of the presence or absence of large-vessel stenoses. Dysfunction includes the impairment of platelet and vascular responsiveness to autocidal coronary vasodilators, such as nitric oxide, prostacyclin, and hydrogen sulphide, and predisposes both to coronary vasoconstriction and to a propensity for microthrombus formation. These findings emphasise the need for new directions in medical therapeutics for patients with SAP, as well as a wide range of other cardiovascular disorders.<\/jats:p>","DOI":"10.3390\/ijms241411287","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T01:40:02Z","timestamp":1689039602000},"page":"11287","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Coronary \u201cMicrovascular Dysfunction\u201d: Evolving Understanding of Pathophysiology, Clinical Implications, and Potential Therapeutics"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6529-528X","authenticated-orcid":false,"given":"Chun Yeung","family":"Kei","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Adelaide, Adelaide 5371, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9657-9923","authenticated-orcid":false,"given":"Kuljit","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Griffith University, Southport 4111, Australia"},{"name":"Gold Coast University Hospital, Gold Coast 4215, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustem F.","family":"Dautov","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Queensland, Woolloongabba 4102, Australia"},{"name":"Prince Charles Hospital, Brisbane 4032, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8244-8655","authenticated-orcid":false,"given":"Thanh H.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Adelaide, Adelaide 5371, Australia"},{"name":"Northern Adelaide Local Health Network, Adelaide 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliy Y.","family":"Chirkov","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Adelaide, Adelaide 5371, Australia"},{"name":"Basil Hetzel Institute for Translational Research, Adelaide 5011, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Horowitz","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Adelaide, Adelaide 5371, Australia"},{"name":"Basil Hetzel Institute for Translational Research, Adelaide 5011, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0002-9149(74)90743-7","article-title":"Physiologic basis for assessing critical coronary stenosis: Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve","volume":"33","author":"Gould","year":"1974","journal-title":"Am. J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jcmg.2009.06.004","article-title":"Does coronary flow trump coronary anatomy?","volume":"2","author":"Gould","year":"2009","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.109.900191","article-title":"Primary coronary microvascular dysfunction: Clinical presentation, pathophysiology, and management","volume":"121","author":"Lanza","year":"2010","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jcin.2020.04.040","article-title":"The Impact of Coronary Physiology on Contemporary Clinical Decision Making","volume":"13","author":"Kogame","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional Flow Reserve\u2013Guided PCI versus Medical Therapy in Stable Coronary Disease","volume":"367","author":"Pijls","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jcin.2016.01.046","article-title":"Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes","volume":"9","author":"Agarwal","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jcin.2018.03.003","article-title":"A Song of Pressure and Flow, or There and Back Again","volume":"11","author":"Howard","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jacc.2015.12.053","article-title":"Coronary Flow Reserve and Microcirculatory Resistance in Patients with Intermediate Coronary Stenosis","volume":"67","author":"Lee","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","article-title":"Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis: 5-Year Follow-Up of the DEFER Study","volume":"49","author":"Pijls","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/eurheartj\/ehv452","article-title":"Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial","volume":"36","author":"Zimmermann","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1408758","article-title":"Fractional Flow Reserve\u2013Guided PCI for Stable Coronary Artery Disease","volume":"371","author":"Fearon","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-Year Outcomes with PCI Guided by Fractional Flow Reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJMe1208620","article-title":"Which is more enduring\u2014FAME or COURAGE?","volume":"367","author":"Boden","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMe1410336","article-title":"FFR-guided PCI\u2014FAME may not be so fleeting after all","volume":"371","author":"Rade","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_16","first-page":"31","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): A double-blind, randomised controlled trial","volume":"391","author":"Thompson","year":"2017","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial Invasive or Conservative Strategy for Stable Coronary Disease","volume":"382","author":"Maron","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/eurheartj\/ehab509","article-title":"Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial","volume":"43","author":"Cyr","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.120.047987","article-title":"Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons","volume":"143","author":"Chaitman","year":"2021","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacc.2009.03.063","article-title":"Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes: An Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial","volume":"54","author":"Prasad","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/CIRCULATIONAHA.118.033801","article-title":"Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease","volume":"138","author":"Howard","year":"2018","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1161\/01.CIR.0000080700.98607.D1","article-title":"Novel Index for Invasively Assessing the Coronary Microcirculation","volume":"107","author":"Fearon","year":"2003","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIRCULATIONAHA.111.050427","article-title":"Improved cardiac risk assessment with noninvasive measures of coronary flow reserve","volume":"124","author":"Murthy","year":"2011","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.jcmg.2018.08.018","article-title":"Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events","volume":"12","author":"Indorkar","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12350-017-1110-x","article-title":"Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC","volume":"25","author":"Murthy","year":"2017","journal-title":"J. Nucl. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4244\/EIJV5I8A158","article-title":"Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis","volume":"5","author":"Melikian","year":"2010","journal-title":"Eurointervention"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCINTERVENTIONS.113.000953","article-title":"Thermodilution-Derived Coronary Microvascular Resistance and Flow Reserve in Patients with Cardiac Syndrome X","volume":"7","author":"Luo","year":"2014","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4244\/EIJV9I9A181","article-title":"Reference interval for the index of coronary microvascular resistance","volume":"9","author":"Solberg","year":"2014","journal-title":"Eurointervention"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e005361","DOI":"10.1161\/CIRCINTERVENTIONS.117.005361","article-title":"Invasive Assessment of the Coronary Microvasculature: The Index of Microcirculatory Resistance","volume":"10","author":"Fearon","year":"2017","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10554-020-01831-7","article-title":"Angiography-derived index of microcirculatory resistance as a novel, pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction","volume":"36","author":"Scarsini","year":"2020","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"735743","DOI":"10.3389\/fcvm.2021.735743","article-title":"Diagnostic Value of Angiography-Derived IMR for Coronary Microcirculation and Its Prognostic Implication After PCI","volume":"8","author":"Dai","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jcin.2021.05.027","article-title":"Functional Coronary Angiography\u2013Derived Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial Infarction","volume":"14","author":"Choi","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: A quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/eurheartj\/ehw157","article-title":"Myocardial blush and microvascular reperfusion following manual thrombectomy during percutaneous coronary intervention for ST elevation myocardial infarction: Insights from the TOTAL trial","volume":"37","author":"Sharma","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.97.23.2302","article-title":"Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle Myocardial Infarction Study Group","volume":"97","author":"Liem","year":"1998","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of Ischemic Heart Disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary Microvascular Dysfunction across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review","volume":"78","author":"Montone","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2174\/1381612824666180625142341","article-title":"Coronary Microcirculation in Ischemic Heart Disease","volume":"24","author":"Kuebler","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/bja\/aer269","article-title":"Shedding of the coronary endothelial glycocalyx: Effects of hypoxia\/reoxygenation vs. ischaemia\/reperfusion","volume":"107","author":"Annecke","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bcp.12629","article-title":"Degradation of the endothelial glycocalyx in clinical settings: Searching for the sheddases","volume":"80","author":"Becker","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/10739680590894966","article-title":"Microvascular Rheology and Hemodynamics","volume":"12","author":"Lipowsky","year":"2005","journal-title":"Microcirculation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","article-title":"The glycocalyx: A novel diagnostic and therapeutic target in sepsis","volume":"23","author":"Uchimido","year":"2019","journal-title":"Crit. Care"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.freeradbiomed.2009.05.034","article-title":"Role of glycocalyx in flow-induced production of nitric oxide and reactive oxygen species","volume":"47","author":"Kumagai","year":"2009","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"557235","DOI":"10.3389\/fimmu.2020.557235","article-title":"Pre-Existing Cytokine and NLRP3 Inflammasome Activation and Increased Vascular Permeability in Diabetes: A Possible Fatal Link with Worst COVID-19 Infection Outcomes?","volume":"11","author":"Lambadiari","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1089\/ars.2021.0027","article-title":"Oxidative Stress and Endothelial Dysfunction in Sepsis and Acute Inflammation","volume":"35","author":"Joffre","year":"2021","journal-title":"Antioxid. Redox Signal."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"734276","DOI":"10.3389\/fcell.2021.734276","article-title":"Update on the role of the endothelial glycocalyx in angiogenesis and vascular inflammation","volume":"9","author":"Hu","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jcmg.2020.06.044","article-title":"The Clinical Spectrum of Myocardial Infarction and Ischemia with Nonobstructive Coronary Arteries in Women","volume":"14","author":"Hoogen","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Liu, Y., Chen, S., Liu, S., Sun, G., Sun, Z., and Liu, H. (2022). Association of endothelial glycocalyx shedding and coronary microcirculation assessed by an angiography-derived index of microcirculatory resistance in patients with suspected coronary artery disease. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.950102"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.117.027575","article-title":"Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment\u2013Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction])","volume":"136","author":"Pasupathy","year":"2017","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/bph.15388","article-title":"Impairment of platelet NO signalling in coronary artery spasm: Role of hydrogen sulphide","volume":"178","author":"Imam","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/eurheartj\/ehq390","article-title":"Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: Possible role in sustained platelet activation","volume":"32","author":"Gresele","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood-2016-06-724245","article-title":"A novel mechanism regulating human platelet activation by MMP-2\u2013mediated PAR1 biased signaling","volume":"129","author":"Sebastiano","year":"2017","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/EJA.0000000000000085","article-title":"Protection of glycocalyx decreases platelet adhesion after ischaemia\/reperfusion","volume":"31","author":"Chappell","year":"2014","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Grushko, O.G., Cho, S., Tate, A.M., Rosenson, R.S., Pinsky, D.J., Haus, J.M., Hummel, S.L., and Goonewardena, S.N. (Cardiovasc. Drugs Ther., 2022). Glycocalyx Disruption Triggers Human Monocyte Activation in Acute Heart Failure Syndromes, Cardiovasc. Drugs Ther., in press.","DOI":"10.1007\/s10557-022-07390-4"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease\u2014A 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2015","journal-title":"Acta Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric Oxide and Peroxynitrite in Health and Disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"107023","DOI":"10.1016\/j.vph.2022.107023","article-title":"Factors influencing the soluble guanylate cyclase heme redox state in blood vessels","volume":"145","author":"Tawa","year":"2022","journal-title":"Vasc. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/FJC.0000000000000167","article-title":"Hypoxic Vasospasm Mediated by cIMP: When Soluble Guanylyl Cyclase Turns Bad","volume":"65","author":"Gao","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Chirkov, Y.Y., Nguyen, T.H., and Horowitz, J.D. (2022). Impairment of Anti-Aggregatory Responses to Nitric Oxide and Prostacyclin: Mechanisms and Clinical Implications in Cardiovascular Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031042"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199210000-00020","article-title":"Prostacyclin and Nitric Oxide Contribute to the Vasodilator Action of Acetylcholine and Bradykinin in the Intact Rabbit Coronary Bed","volume":"20","author":"Lamontagne","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Kimura, H. (2021). Hydrogen Sulfide (H(2)S) and Polysulfide (H(2)S(n)) Signaling: The First 25 Years. Biomolecules, 11.","DOI":"10.3390\/biom11060896"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.niox.2014.12.004","article-title":"Role of cGMP in hydrogen sulfide signaling","volume":"46","author":"Bibli","year":"2015","journal-title":"Nitric. Oxide"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2018.01.017","article-title":"Regulation of vascular tone homeostasis by NO and H2S: Implications in hypertension","volume":"149","author":"Gheibi","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_66","first-page":"431","article-title":"Cardioprotection by H2S Donors: Nitric Oxide-Dependent and -Independent Mechanisms","volume":"358","author":"Chatzianastasiou","year":"2016","journal-title":"Experiment"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bcp.2017.11.011","article-title":"The role of hydrogen sulfide in cyclic nucleotide signaling","volume":"149","author":"Cao","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"105119","DOI":"10.1016\/j.phrs.2020.105119","article-title":"Hydrogen sulfide: An endogenous regulator of the immune system","volume":"161","author":"Dilek","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1074\/jbc.M117.806869","article-title":"Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation","volume":"293","author":"Castelblanco","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.fjc.0000176729.51819.a6","article-title":"Angiotensin-(1-7) Enhances Anti-Aggregatory Effects of the Nitric Oxide Donor Sodium Nitroprusside","volume":"46","author":"Rajendran","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCRESAHA.116.308290","article-title":"The Secret Life of Telomerase","volume":"118","author":"Welsh","year":"2016","journal-title":"Circ. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/ATVBAHA.116.307518","article-title":"Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase. Arterioscler. Thromb","volume":"36","author":"Gutterman","year":"2016","journal-title":"Vasc. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","article-title":"Mast cells and inflammation","volume":"1822","author":"Delivanis","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: Armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ashina, K., Tsubosaka, Y., Nakamura, T., Omori, K., Kobayashi, K., Hori, M., Ozaki, H., and Murata, T. (2015). Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132367"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/01.ATV.0000193622.77294.57","article-title":"Platelet nitric oxide responsiveness: A novel prognostic marker in acute coronary syndromes","volume":"25","author":"Willoughby","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.15420\/ecr.2021.15","article-title":"Microvascular Angina: Diagnosis and Management","volume":"16","author":"Aldiwani","year":"2021","journal-title":"Eur. Cardiol. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.jcin.2020.05.052","article-title":"Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease","volume":"13","author":"Ford","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2017.09.016","article-title":"Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries","volume":"70","author":"Aziz","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_80","first-page":"63","article-title":"Ischemia with Nonobstructive Coronary Arteries: Insights from the ISCHEMIA Trial. JACC Cardiovasc","volume":"16","author":"Reynolds","year":"2023","journal-title":"Imaging"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/00005344-199506000-00015","article-title":"Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1","volume":"25","author":"Chirkov","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.CIR.100.2.129","article-title":"Nitrate Resistance in Platelets From Patients With Stable Angina Pectoris","volume":"100","author":"Chirkov","year":"1999","journal-title":"Circulation"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-9343(59)90003-8","article-title":"Angina pectoris. I. A variant form of angina pectoris; preliminary report","volume":"27","author":"Prinzmetal","year":"1959","journal-title":"Am. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000063121","article-title":"The Coronary Slow Flow Phenomenon\u2014A New Coronary Microvascular Disorder","volume":"97","author":"Beltrame","year":"2002","journal-title":"Cardiology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2004.03.055","article-title":"The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon","volume":"44","author":"Beltrame","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3892\/mmr.2020.11274","article-title":"Telomerase and telomeres in aging theory and chronographic aging theory (Review)","volume":"22","author":"Razgonova","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/CIRCRESAHA.115.307918","article-title":"Critical Role for Telomerase in the Mechanism of Flow-Mediated Dilation in the Human Microcirculation","volume":"118","author":"Beyer","year":"2016","journal-title":"Circ. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCRESAHA.118.312563","article-title":"Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease","volume":"123","author":"Donato","year":"2018","journal-title":"Circ. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"38029","DOI":"10.1074\/jbc.M509039200","article-title":"Regulation of oxidative stress by the anti-aging hormone klotho","volume":"280","author":"Yamamoto","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.semnephrol.2014.09.003","article-title":"The Role of Klotho on Vascular Calcification and Endothelial Function in Chronic Kidney Disease","volume":"34","author":"Vervloet","year":"2014","journal-title":"Semin. Nephrol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1128\/MCB.01215-12","article-title":"Hydrogen Sulfide, the Next Potent Preventive and Therapeutic Agent in Aging and Age-Associated Diseases","volume":"33","author":"Zhang","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e000973","DOI":"10.1161\/JAHA.114.000973","article-title":"Aging of the nitric oxide system: Are we as old as our NO?","volume":"3","author":"Sverdlov","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1016\/j.ijcard.2013.07.159","article-title":"Reciprocal regulation of NO signaling and TXNIP expression in humans: Impact of aging and ramipril therapy","volume":"168","author":"Sverdlov","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.bjp.0706999","article-title":"The calcium ionophore A23187 induces endothelium-dependent contractions in femoral arteries from rats with streptozotocin-induced diabetes","volume":"150","author":"Shi","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0735-1097(95)00522-6","article-title":"Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus","volume":"27","author":"Williams","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2006.08.053","article-title":"The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration","volume":"49","author":"Kucia","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1161\/ATVBAHA.118.310839","article-title":"Endothelial Glycocalyx as a Shield against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases. Arterioscler. Thromb","volume":"38","author":"Dogne","year":"2018","journal-title":"Vasc. Biol."},{"key":"ref_98","first-page":"2334","article-title":"From the Epicardial Vessels to the Microcirculation: The Coronary Vasculature at the Crossroad of HFpEF. JACC Cardiovasc","volume":"14","author":"Chiribiri","year":"2021","journal-title":"Imaging"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2020.10.005","article-title":"COVID-19\u2014A vascular disease","volume":"31","author":"Siddiqi","year":"2021","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Mongelli, A., Barbi, V., Zamperla, M.G., Atlante, S., Forleo, L., Nesta, M., Massetti, M., Pontecorvi, A., Nanni, S., and Farsetti, A. (2021). Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors. Int. J. Mol. Sci., 22.","DOI":"10.1101\/2021.04.23.21255973"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(20)32011-0","article-title":"Circulating ACE2: A novel biomarker of cardiovascular risk","volume":"396","author":"Ramchand","year":"2020","journal-title":"Lancet"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(20)31964-4","article-title":"Plasma ACE2 and risk of death or cardiometabolic diseases: A case-cohort analysis","volume":"396","author":"Narula","year":"2020","journal-title":"Lancet"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpha.2017.12.003","article-title":"S-Nitroso-N-acetyl-L-cysteine ethyl ester (SNACET) and N-acetyl-L-cysteine ethyl ester (NACET)-Cysteine-based drug candidates with unique pharmacological profiles for oral use as, NO.; H(2)S and GSH suppliers and as antioxidants: Results and overview","volume":"8","author":"Giustarini","year":"2018","journal-title":"J. Pharm. Anal."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1096\/fj.14-257113","article-title":"Hydrogen sulfide inhibits Cav3.2 T-type Ca 2+ channels","volume":"28","author":"Elies","year":"2014","journal-title":"FASEB J."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2019.04.003","article-title":"Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin","volume":"4","author":"Juni","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","article-title":"Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics","volume":"73","author":"Antonio","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_114","first-page":"102","article-title":"The cystathionine-\u03b3-lyase\/hydrogen sulfide pathway mediates the trimetazidine-iinduced protection of H9c2 cells against hypoxia\/reoxygenation-induced apoptosis and oxidative stress","volume":"22","author":"Zheng","year":"2019","journal-title":"Anatol. J. Cardiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2015.05.071","article-title":"Mast cell stabilizers","volume":"778","author":"Zhang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"12681","DOI":"10.1038\/s41598-022-16763-6","article-title":"Empagliflozin mitigates endothelial inflammation and attenuates endoplasmic reticulum stress signaling caused by sustained glycocalyx disruption","volume":"12","author":"Campeau","year":"2022","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/14\/11287\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:10:04Z","timestamp":1760127004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/14\/11287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":116,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ijms241411287"],"URL":"https:\/\/doi.org\/10.3390\/ijms241411287","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]}}}